|
|
Oral Combination Therapy: The PAtH to Improved Patient Care in PAH
Are you interested in finding out how you can more effectively manage your patients with PAH? In this short “How I Do It” vlog, expert faculty Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan discusses recommendations for the use of oral combination therapies in PAH along with her experiences and considerations with these treatment options in clinical practice. Stay on the right PAHth with therapeutic options available for your patients ... |
|
|
Management of Cancer Pain: Current Guidelines
STATEMENT OF NEED
Patients with cancer often suffer from a range of symptoms that negatively impact their quality of life. Among the most significant of these symptoms is pain, which can be caused by surgery, radiation, chemotherapy, targeted therapy, diagnostic procedures, and/or supportive care measures. Between 20% and 50% of patients with cancer experience pain, including moderate-to-severe pain, in approximately 80% of patients with advanced-stage cancer (NCI, 2021). Despite awareness ... |
|
|
Community Practice Connections™: Improving Prognosis in SSc-ILD: Best Practices in Diagnosis, Optimizing Clinical Management, and Efficient Patient Communication
Target Audience
This activity is intended for pulmonologists and critical care specialists. Rheumatologists, dermatologists, clinical immunologists, allergists, primary care clinicians, nurses, nurse practitioners, physician assistants, and other specialists interested in the treatment of patients with SSc-ILD are also invited to participate in the educational curriculum.
Activity Overview
Interstitial lung disease (ILD) is a frequent and debilitating complication of systemic sclerosi... |
|
|
Fact or Fiction? Test Your Readiness to Provide Nursing Care for Youth with Seizure Clusters Outside of the Hospital
Target Audience
This activity is designed to meet the educational needs of nurses, including school nurses, who are involved in the care of children and adolescents.
Program Overview
Epilepsy is one of the most common chronic diseases among children and adolescents, and seizures are a frequent school health emergency. Effective rescue therapies are now available for use outside of the hospital setting to treat seizure clusters, which can progress into a seizure emergency. Nurses play a cr... |
|
|
Transforming the Modern Management of Relapsing Multiple Sclerosis
In this activity Patricia Coyle, MD and Amy Perrin Ross, APN, MSN, CNRN, MSCN discuss the current management of MS, with a special focus on assessing and monitoring patients’ cognitive health. |
|
|
Clinical Consultations™: Redefining Dry Eye Disease - Focusing on the Tear Film: Stability, Diagnosis, Homeostasis, & COVID-19 Considerations in DED
Target Audience
This online educational activity is directed toward ophthalmologists and optometrists who care for patients affected by dry eye disease (DED). Other health care providers involved in the care of patients with DED are also invited to participate.
Activity Overview
Dry eye disease (DED) affects about 7% of the US population, and if left untreated, can affect vision and negatively impact quality of life. Eye care experts in DED have recently developed a new definition of ... |
|
|
Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now
Program Overview
This Clinical ConsultationsTM is a video-based program in which two experts discuss the management of patients with multiple sclerosis (MS) and SARS-CoV-2 vaccinations. In this activity, the faculty focus on the effects of disease modifying therapies (DMTs) on vaccine practices, specifically the mRNA vaccines for SARS-CoV-2. This engaging format is designed to help clinicians identify best practices in the management of patients with MS and to improve outcomes for their pat... |
|
|
From Risk Assessment to Treatment: Real-World Approaches to PAH
In this clinical commentary, join cardiology expert Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan and pulmonology expert Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center as they provide real-world advice on the management of pulmonary arterial hypertension (PAH). These experts will discuss their best practices for:
• Risk assessment and stratification
• Use of oral combination therapies... |
|
|
COVID-19 In the Pipeline Therapeutics
Target Audience
This activity is intended for health care providers in the care of patients with COVID-19.
This activity is supported by independent educational grants from Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., and Eli Lilly and Company.
Program Overview:
In this on-demand video webinar, Dr. Paul Auwaerter discusses potential COVID-19 treatments currently in the pipeline. Topics:
Outpatient treatments: inhaled remdesivir, oral antivirals, inhaled budesonide, and monoclon... |
|
|
DOACs in Transition: Examining the Challenges and Complexity of Transitions in Care
Why should hospitalists, cardiologists, and other clinicians care about optimal post-discharge prophylaxis in patients with acute medical illness? What strategies are available to better ensure optimal post-discharge prophylaxis in this patient population? This clinical commentary features leading thrombosis expert, Dr. Alex Spyropoulos, and a multidisciplinary panel, covering these important questions and how clinicians can ensure that they optimally incorporate these recommendations into the... |
|
|
7-Night Alaska CME AWAY® Cruise - Rheumatology & Family Medicine
Vancouver, British Columbia • Sitka, Alaska • Hubbard Glacier, Alaska (Cruising) • Juneau, Alaska • Ketchikan, Alaska |
|
|
7-Night Alaska CME AWAY® Cruise - Forensic Dentistry, Domestic Violence, Oral Cancer and HPV and Psychiatric Illness and Dentistry: Challenges for Oral Care
Vancouver, British Columbia • Sitka, Alaska • Hubbard Glacier, Alaska (Cruising) • Juneau, Alaska • Ketchikan, Alaska |
|
|
Mid-Year Update: Altering the Course of Cancer in Primary Care: Early Detection for Better Long-term Outcomes
Target Audience
This educational program is directed toward primary care physicians, nurse practitioners, physician assistants, and other health care professionals involved in screening patients for cancer.
Activity Overview
This online educational activity is designed to provide expert interpretation of new and emerging blood tests for cancer screening, with a forward-looking perspective on how blood-based cancer screening might impact clinical practice. An overview of current screening ... |
|
|
Cleveland Clinic Diabetes Therapeutics, Technology and Surgery (Online Streaming On Demand)
For over twenty five years, Cleveland Clinic has been at the forefront of diabetes treatment, research and education. Its world class faculty has designed Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of management strategies and research on the complications of this disease. It includes a detailed analysis of therapeutic options applicable to type 1 and type 2 diabetes, as well as their complications. Worth 6.25 AMA PRA Category I Credits™, this enduring mat... |
|
|
Dreams of Tahiti Cruise on Windstar: Treatment Considerations in Isolated Communities
Discover paradise in French Polynesia! Join PES for 8 nights to explore the best of the South Pacific with its crystal-clear lagoons, colorful coral gardens, lush rainforests, and Polynesian culture—while sailing aboard the 148-guest sailing yacht, Windstar Wind Spirit!
This Seminar is planned for 12 Continuing Education Credit Hours.
CME/CE Professional Seminar Fee: $695
Seminar Attendance Fee: $450
CME/CE credits, Certificates of Completion and possible tax deductible gui... |
|
|
A Closer Look at PAH Diagnosis, Screening, and Risk Assessment
In this short “How I Do It” vlog, expert faculty Dr. John Ryan, Director, Pulmonary Hypertension Comprehensive Care Center, University of Utah Hospital showcases personal experiences incorporating updated recommendations in clinical practice as well as diagnostic approaches, screening methods, and the importance of risk assessment. Upon completion of this activity, clinicians will be better able to incorporate effective screening techniques and appropriate diagnostic and risk assessment to... |
|
|
PAH and COVID-19: A Patient’s Journey
PAH patient and advocate, Jen C., shares her perspective, experience, and challenges with managing her PAH every day and during her COVID-19 infection. Learn from her journey and consider how her experiences may improve your own PAH patients’ outcomes. |
|
|
Emerging Developments in the Treatment of Generalized Myasthenia Gravis
This activity will address the current treatment landscape as it compares to clinical trials in development focusing on FcRn modulation as a therapeutic target for myasthenia gravis (MG). We will review FcRn inhibitor therapeutic agents and discuss how these therapies may effectively change the management of patients with MG. |
|
|
Who’s On The Tightrope? Understanding Patients With Chronic Polyvascular Disease
Many atherosclerotic cardiovascular disease (ASCVD) patients do well after suffering a heart attack or stroke, but frequently, these patients continue to be at high risk for recurrent cardiovascular events and are not necessarily stable. It is important to understand the patients, particularly those with polyvascular disease, at higher risk for recurrent events. Are you current with how to best manage these patients? Find out in this short vlog, where Dr. Christian Ruff from Brigham and Women'... |
|
|
5-Night Key West & Mexico CME AWAY® Cruise - Psychiatry & Plastic Medicine Update
Miami, Florida • Key West, Florida • Cozumel, Mexico |
|
|
10-Night Venice, Turkey & Greek Islands CME AWAY® Cruise - Clinical Updates in Palliative Care & Emergency Medicine
Venice, Italy • Olympia (Katakolon), Greece • Santorini, Greece • Ephesus (Kusadasi), Turkey • Mykonos, Greece • Athens (Piraeus), Greece • Chania (Souda), Crete, Greece • Zakynthos, Greece |
|
|
10-Night Great Barrier Reef CME AWAY® Cruise - Diabetes, Mood and Sleep Disorders, Osteoporosis, Thyroid Disease & Pain Management
Sydney, Australia • Eden, Australia • Airlie Beach, Qld, Australia • Cairns (Yorkey's Knob), Australia • Port Douglas, Australia • Willis Island (Cruising), Australia |
|
|
12-Night Patagonia & Argentina CME AWAY® Cruise - Emergency Medicine & Pediatrics Update
Valparaiso, Chile • Puerto Montt, Chile • Punta Arenas, Chile • Ushuaia, Argentina • Cape Horn, Chile • Puerto Madryn, Argentina • Montevideo, Uruguay • Buenos Aires, Argentina |
|
|
12-Night Japanese Cherry Blossom CME AWAY® Cruise - Updates in Neurology & Infectious Diseases
Tokyo (Yokohama), Japan • Aomori, Japan • Hakodate, Japan • Busan, South Korea • Hiroshima, Japan • Kobe, Japan • Kyoto (Osaka), Japan • Mt Fuji (Shimizu), Japan |
|
|
4-Night Rwanda Gorilla Trek CME AWAY® Land Tour
SPACE ON THIS TRIP IS EXTREMELY LIMITED & MUST BE SECURED WELL IN ADVANCE. GORILLA PERMITS ARE IN HIGH DEMAND. ATTENDANCE AT THIS CME IS LIMITED TO THOSE SIGNED UP FOR AND ARE ATTENDING THE CME SESSIONS IN KENYA IMMEDIATELY PRIOR TO THIS TRIP.
Kigali, Rwanda • Volcanoes National Park, Rwanda |
|
|
Reducing Healthcare Disparities for PAH Patients
Very few studies have assessed the impact of healthcare disparities on PAH, despite the potential adverse impacts. One such study from Talwar et al reported that minority PAH patients may be at risk for worse outcomes due to lack of healthcare access, insurance gaps, and socioeconomic status. Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, draws from his own experience of treating PAH patients and shares how increased awareness and education can... |
|
|
Strategies for Successfully Diagnosing and Treating Tardive Dyskinesia: Enlisting the Help of Caregivers, Improving the Lives of Patients
Target Audience
This activity is designed to meet the educational needs of psychiatrists as well as advanced practice psychiatry clinicians who have an opportunity to care for patients with tardive dyskinesia.
Program Overview
At any given time, roughly 1 of every 4 patients taking antipsychotics experiences tardive dyskinesia (TD), a debilitating condition characterized by involuntary movements of the tongue, lips, face, trunk, and extremities. Fortunately, effective pharmacologic tr... |
|
|
Hard to Swallow: Bridging Knowledge Gaps in Eosinophilic Esophagitis
Did you know that the incidence of eosinophilic esophagitis (EoE) is increasing rapidly? Are you familiar with the burdens faced by adult and pediatric patients living with EoE? In this multi-module activity led by an interdisciplinary panel, access practical guidance and supplemental resources on the management and treatment of EoE. Navigate at your own pace through video modules and an interactive infographic with animated content and expert commentary.
Faculty discussion will focus on:
... |
|
|
Hot Topics in Oncology – Focus on the Immune Checkpoint Inhibitors (ICIs)
The immune checkpoint inhibitors (ICIs) continue to break ground in a multitude of cancer types. With ever-evolving data and recommendations, oncology clinicians must keep pace with the latest ICI updates.
This recorded CME-certified session tackles questions surrounding topics related to immune checkpoint inhibitors with discussion on:
• Role of biomarkers with ICI selection and monitoring
• Latest expanded ICI indications
• Immune-related adverse events
This session also featu... |
|
|
Treatment Considerations for PAH Patients During the Pandemic
Are you taking the right precautions to ensure your patients with PAH are safely managed during COVID-19? Are you employing effective therapeutic management strategies with your PAH patients during the pandemic? In this short CME-certified vlog, leading pulmonologist Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, discusses how to effectively manage therapy for PAH during the pandemic, including those who are COVID-19-infected, taking into accou... |
|
|
Enhancing the Clinical Outcomes of Patients with Extensive–Stage Small Cell Lung Cancer
Anne Chiang, MD, PhD, Yale School of Medicine, a leading expert on small cell lung cancer, for an in-depth presentation on patient outcomes in extensive-small cell lung cancer. Dr. Chiang will present evidence-based advice regarding emerging therapies, strategies for targeted treatments and immunotherapy, optimization of individual patient treatment plans, managing adverse events, and much more! Start the activity now!
An estimated 228,820 new cases of lung cancer are reported in the United... |
|
|
Cleveland Clinic State of the Art Echocardiography (Online & DVD-ROM)
Cleveland Clinic’s State of the Art Echocardiography highlights practical issues in echocardiography, featuring insight and real world cardiovascular clinical practice cases from nearly 30 internationally renowned experts. This activity provides guidance for optimal utilization of echocardiography in managing valvular heart disease, heart failure, device therapies, cardiomyopathies and endocarditis. Special sessions will be dedicated to structural heart interventions, adult congenital cardi... |
|
|
Alpha-1 Antitrypsin Deficiency for Nurse Practitioners
Alpha-1 Antitrypsin Deficiency (Alpha-1) is a common genetic disease that is underrecognized, underdiagnosed and often misdiagnosed as COPD or asthma. It can cause liver and lung disease. The liver makes a protein called alpha-1 antitrypsin that goes into the bloodstream. This protein protects the lungs and allows them to work normally. If there is not enough alpha-1 antitrypsin, it is called alpha-1 antitrypsin deficiency. Although Alpha-1 is one of the most common genetic life-threatening di... |
|
|
11-Night Quito & The Galapagos Islands CME AWAY® Cruise - Family Medicine, Psychiatry & Oncology
Quito, Ecuador • Baltra Island (Galapagos) • Daphne Major (Cruising) • Gardner Bay (Espanola) • Punta Suarez • Cormorant Point, Floreana Island • Post Office Bay, Floreana Island • Moreno Point, Isabela Island • Urvina Bay, Isabela Island • Espinoza Point, Fernandina Island • Vicente Roca Point, Isabela Island • South Plaza (Santa Cruz Island) • Dragon Hill (Santa Cruz Island) • Puerto Ayora, Santa Cruz Island
|
|
|
Differentiators When Choosing Novel Treatment Options for EDS
Reducing excessive daytime sleepiness (EDS) is an important treatment goal for patients with narcolepsy or obstructive sleep apnea (OSA). In order to achieve reduced EDS, cataplexy and sleep paralysis/hypnagogic hallucinations must be controlled to improve disturbed nighttime sleep, which then improves fatigue and brain fog and reduces psychosocial dysfunction, therefore improving quality of life (QoL). The latest efficacy and safety data should be reviewed, and considerations for treatment se... |
|
|
Matching Treatment Choice to the Pathophysiology of Sleep
The neurobiology of excessive daytime sleepiness (EDS) in obstructive sleep apnea (OSA) has no identified pathophysiology. This can make it difficult for clinicians to determine a target for therapeutic intervention; therefore, awareness of the mechanisms of action of current and novel therapies is vital when selecting an optimal treatment.
In the second episode of this CME Outfitters podcast series on EDS, expert faculty will focus on identifying key neurotransmitters involved in the sleep... |
|
|
9-Night Kenya CME AWAY® Land Tour - Neurology and Orthopedics: Brain vs Brawn
The concept of the safari was born in Kenya where in Kiswahili the word
safari means "journey”. East Africa has the reputation as the quintessential safari destination for good reason. The region’s dramatic contrasts and endless array of ecosystems showcases a variety of wildlife, making this one of the top destinations for African safari vacationers. |
|
|
Optimal Prehospital Management of Seizure Emergencies
Target Audience
This activity was developed for adult and pediatric neurologists, primary care and osteopathic physicians, pediatricians, neurology nurses, school nurses, advance practice providers, and all other healthcare providers who interact with patients who have epilepsy.
Program Overview
In this program, the faculty will review and provide updates on the guidelines for managing seizure emergencies and address how participants can reduce the barriers to prehospital treatment th... |
|
|
10-Night France, Spain & Portugal CME AWAY® Cruise - State of the Art Management of Pain, Wellness & Practical Mindfulness
Southampton, England • Bordeaux, France • St. Jean De Luz, France • Bilbao, Spain • Gijon, Spain • La Coruna, Spain • Porto (Leixoes), Portugal •
Lisbon, Portugal |
|
|
11-Night Egypt & Israel CME AWAY® Cruise - Updates in Cardiology & Emergency Medicine
Athens (Piraeus), Greece • Alexandria, Egypt • Port Said, Egypt • Jerusalem (Ashdod), Israel • Haifa, Israel • Limassol, Cyprus • Athens (Piraeus), Greece
|
|
|
13-Night British Isles CME AWAY® Cruise - Pediatrics, Endocrinology, Allergy & Immunology Update
Southampton, England • Edinburgh (Leith), Scotland • Dundee, Scotland • Invergordon, Scotland • Belfast, Northern Ireland • Glasgow (Greenock), Scotland • Douglas, Isle Of Man • Dublin, Ireland |
|
|
7-Night St. Lucia CME AWAY® Resort - Forensic Dentistry, Domestic Violence, Oral Cancer and HPV and Psychiatric Illness and Dentistry: Challenges for Oral Care
Pigeon Island Gros Islet, St. Lucia
An idyllic all-inclusive resort located on its very own peninsula, Sandals Grande St. Lucian is often described as the “closest vacation to a picture-perfect postcard.” Cradled to the west by Rodney Bay – boasting the calmest waters in all of Saint Lucia – and to the east by the majestic Atlantic Ocean, this magnificent adults-only resort showcases awe-inspiring panoramic views and Over-The-Water Bungalows that will linger in your heart forever. V... |
|
|
18-Night South America CME AWAY® Cruise - Osteoarthritis, Medical Cannabis, Mood Disorders, Elder Care, Concussions, Exercise and Pregnancy and Pain Management
Bridgetown, Barbados • Willemstad, Curaçao • Oranjestad, Aruba • Cartagena, Columbia • Panama Canal Transit • Manta, Ecuador • Salaverry, Peru • Lima (Callao), Peru • Arica, Chile • Valparaiso, Chile |
|
|
10-Night Italy & France CME AWAY® Cruise - Endodontics: What’s Old, What’s New & What Works
Rome (Civitavecchia), Italy • Florence/Pisa(La Spezia), Italy • Cannes, France • Provence (Toulon), France • Barcelona, Spain • Cagliari, Sardinia • Sicily (Messina), Italy • Naples, Italy |
|
|
15-Night Intensive Norway CME AWAY® Cruise - Endocrinology, Gynecology & Women’s Health
London (Greenwich), England • Newcastle, England • Stavanger, Norway • Bergen, Norway • Flåm, Norway • Nordfjordeid, Norway • Geiranger, Norway • Hellesylt, Norway • Molde (Romsdal), Norway • Leknes (Vestvågøy), Norway • Narvik, Norway • Honningsvag (North Cape), Norway • Alta, Norway • Tromsø, Norway • Oslo, Norway |
|
|
12-Night Scandinavia & Russia CME AWAY® Cruise - Review & Pearls in Gastroenterology & Palliative Care
Amsterdam, Netherlands ● Ronne, Bornholm, Denmark ● St. Petersburg, Russia ● Tallinn, Estonia ● Helsinki, Finland ● Stockholm, Sweden ● Copenhagen, Denmark |
|
|
11-Night Svalbard CME AWAY® Cruise - Urology: Everything You Wanted to Know About Prostate Disease & Orthopedics: Everything You Wanted to Know About the Knee
Longyearbyen, Norway • Svalbard Northern Region, Norway • Svalbard Southern Region, Norway • Bear Island (Svalbard), Norway • Skarsvag (Nordkapp), Norway • Gjesværstappan Islands, Norway • Tromsø, Norway • Oslo, Norway |
|
|
Communicating with Cognitively Impaired Individuals
This course helps healthcare professionals to define cognitive impairment, discuss the role of communication and provide strategies on how to effectively communicate with cognitively impaired individuals. |
|
|
HIV/AIDS - Infection Control
This course applies to all healthcare professionals and fulfills the one-time Florida Board requirement for HIV/AIDS by discussing patient care, infection control, testing, public perspectives and legal considerations related to HIV. |
|
|
Best Practices on Controlled Substances and Drug Diversion
The course discusses the best-practices and the risks associated with the safe and effective prescription of controlled substances, along with methods of identifying and preventing drug misuse |
|